DNAnexus and UK Biobank Expand Cloud Research Analysis Platform with Multi-Omics Proteomics Datasets
September 16, 2026 • Source: GEN
DNAnexus scaled the UK Biobank Research Analysis Platform (RAP) to host expanded Olink Explore HT plasma proteomics alongside 500,000 whole-genome sequences.
**Executive Summary (2026-09-16):** DNAnexus scaled the UK Biobank Research Analysis Platform (RAP) to host expanded Olink Explore HT plasma proteomics alongside 500,000 whole-genome sequences. Source: GEN.
Technical Architecture & R&D Impact
Pharma consortium partners including AstraZeneca, Amgen, Johnson & Johnson, and Regeneron utilize DNAnexus Apollo and Spark-backed JupyterLab environments to execute phenome-wide Mendelian randomization and genetically validated target discovery.
Enterprise Biopharma Procurement Takeaways
For computational biology leads, medicinal chemists, and R&D IT architects, this milestone underscores the rapid convergence of wet-lab experimental validation and scalable cloud foundation models during H2 2026. Teams evaluating vendors in the Partnership category should benchmark API reproducibility, GxP audit readiness, and zero-data-retention VPC deployment terms.
Related Products
Published September 16, 2026
More NewsLast updated: September 16, 2026
